Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12615000856516Phase 4Completed
Phase 4, open-label trial of levobupivacaine (3 arms), sponsored by Bakırköy Dr. Sadi Konuk Research and Training Hospital. Primary endpoints: Duration of sensory block, Duration of motor block and 1 more. Started Feb 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12615000856516.